Home | Volume 44 | Article number 92


Antimicrobial profile of coagulase-negative staphylococcus isolates from categories of individuals at a neonatal intensive care unit of a tertiary hospital-Ghana

Antimicrobial profile of coagulase-negative staphylococcus isolates from categories of individuals at a neonatal intensive care unit of a tertiary hospital-Ghana

Innocent Afeke1,&, Kokou Hefoume Amegan-Aho2, Joseph Adu-Amankwaah3, Verner Ndudiri Orish4, Graceful Lord Mensah5, Hintermann Kobina Mbroh6, Ibrahim Jamfaru4, Abdul-Wahab Mawuko Hamid1, Lennox Mac Ankrah4, John Korbuvi7, Anthony Ablordey8


1Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana, 2Department of Pediatrics, School of Medicine, University of Health and Allied Sciences, Ho, Ghana, 3Department of Physiology, Xuzhou Medical University, Xuzhou, Jiangsu, China, 4Department of Microbiology and Immunology, School of Medicine, University of Health and Allied Sciences, Ho, Ghana, 5Department of Pediatrics, Ho Teaching Hospital, Ho, Ghana, 6Department of Obstetrics and Gynecology, Ho Teaching Hospital, Ho, Ghana, 7Department of Pharmacy, Ho Teaching Hospital, Ho, Ghana, 8Department of Bacteriology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana



&Corresponding author
Innocent Afeke, Department of Medical Laboratory Sciences, School of Allied Health Sciences, University of Health and Allied Sciences, Ho, Ghana




Introduction: we compared the antimicrobial resistance profile of young infants' clinical isolates (from blood samples) of Staphylococcus epidermidis and haemolyticus with those colonizing mothers, clinical staff, and students. Also, screened for resistance to the watch and reserve classified groups, antibiotics not prescribed in the Ho Teaching Hospital (HTH), Ghana.


Methods: a cross-sectional study was conducted from March to June 2018 to determine the antimicrobial susceptibility of twenty-one antimicrobials for 123 isolates consisting of 54 S. epidermidis and 69 S. haemolyticus cultured from the participants. VITEK2 was used for antimicrobial susceptibility testing. Staphylococcal species were identified using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF). Statistical analysis was done with Grad-Pad prism.


Results: for S. epidermidis, clinical staff isolates have the highest methicillin-resistant (65%), followed by young infants' (50%) and mothers' and students' twenty-five percent each. Both young infants and clinical staff's S. haemolyticus isolates have 100% methicillin-resistant, while mothers' and students' ones have 82% and 63%, respectively. We have identified resistance to one watch (teicoplanin), two reserves (tigecycline and fosfomycin) antimicrobial groups, and mupirocin, an unclassified group.


Conclusion: identifying coagulase-negative staphylococci (CoNS) resistance to watch and reserve groups of antimicrobials in a non-previously exposed hospital calls for further studies to determine molecular mechanisms of resistance to these antimicrobials.



Introduction    Down

Microorganisms rapidly develop resistance to existing drugs; hence antimicrobial agents of new chemical groups are introduced, and the combined drugs are then used [1]. However, microorganisms' resistance grows faster than new antimicrobials are created. Considering the scale of the problem, the World Health Organization (WHO) has developed a document entitled 'WHO Global Strategy for the Containment of Antibiotic Resistance' [2]. It states that excessive and inappropriate use of antibiotics is considered one of the major causes of the spread of resistance to antimicrobial drugs. Given this, in March 2017, the WHO Essential Medicines List (EML) Working Group classified antibiotics in the EML for children (EMLc) into three groups: access, watch, and reserve [3]. The access group generally contains narrow-spectrum antibiotics recommended as the first and second choice for most common clinical infection syndromes. They are used for commonly encountered susceptible pathogens and show lower resistance potential than antibiotics in the other groups. The watch group contains a generally broader spectrum of antibiotic classes. This group includes antimicrobials with higher resistance potential. It includes most of the highest priority agents among the critically important antimicrobials for human medicine [4] and antibiotics at a relatively high risk of selecting bacterial resistance. Antibiotics in the watch group are suggested to be prioritized as key targets of stewardship programs and monitoring. The reserve group consists of last-resort antibiotics for targeted use in multidrug-resistant infections. This group includes antimicrobial classes that should be reserved for treating confirmed or suspected infections due to multi-drug-resistant organisms. Antibiotics in the reserve group should be treated as "last resort" options; they should be accessible, but their use should be tailored to highly specific patients and settings when all alternatives have failed or are not suitable. To preserve their effectiveness, antibiotics in this group could be protected and prioritized as key targets of national and international stewardship programs involving monitoring and utilization reporting.

Antibiotics are the most frequently used medications in neonates. The neonatal intensive care unit (NICU) houses a Naïve immunocompetent newborn who is highly susceptible to overwhelming infections. In the Ho Teaching Hospital´s (HTH´s) NICU and baby unit, early and decisive treatment with potent antibiotics for neonates with suspected infection is the preferred clinical doctrine owing to the fear of potentially disastrous consequences. The high associated mortality from infections leads neonatal care providers to initiate empirical antibiotic therapy in this hospital. However, antibiotics are often continued in clinical situations where a clear indication of benefit has not been demonstrated. As has already been reported, empiric antibiotic use for 'rule-outs' contributes significantly to overall antibiotic use in neonatal units, making finding strategies for safe antibiotic restriction challenging, especially among preterm infants [5]. An ideal approach to early empirical antibiotic therapy would be one that accurately identifies and treats those at high risk while sparing those at low risk.

Coagulase-negative staphylococci (CoNS), primarily S. epidermidis and S. haemolyticus, are common etiologic agents in neonatal sepsis in low and middle-income countries (LMICs) [6]. There is epidemiological evidence that S. aureus strains resistant to some of the 'Watch' and 'Reserve' WHO classified antimicrobial groups are emerging from low- and middle-income countries (LMICs) where these antimicrobial agents are rarely used due to cost. Data on CoNS especially isolates in the NICUs, are mostly missing. Therefore, this study delivers insight into S. epidermidis and S. haemolyticus species' antimicrobial susceptibility patterns of some of the 'Watch' and 'Reserve' group antimicrobials and mupirocin for these bacterial species cultivated from a resource-limited hospital, where there were no prior exposures of these antimicrobials.



Methods Up    Down

Study population and sample type collected: our study was conducted at the Ho Teaching Hospital (HTH) of Ghana from March to June 2018. The study protocol was approved by the ethics committee of the University of Health and Allied Sciences (UHAS), Ho, Ghana. The study population includes 305 participants, which consist of 118 neonates (babies with the age of 0 - 28 days) and young infants (age range of 29 to 60 days), 68 mothers (transient residence), 59 clinical staff (residence), and 60 students (non-residence, control). The students were newly admitted to the university and had no contact with the hospital. Blood cultures were done for the babies, while nasal swab cultures were done for mothers, clinical staff, and students from the UHAS. We have previously described how these samples were cultured, stored, and shipped to Germany for further analyses [7].

Bacterial isolates: a total of 527 bacterial isolates were collected from the participants. Out of this, antimicrobial susceptibility testing was done for a selected 123 CoNS species consisting of 54 S. epidermidis and 69 S. haemolyticus.

Identification of bacterial isolates: all the bacterial isolates were identified in the Department of Infectious Diseases and Microbiology of the University of Lübeck, Germany, using the MALDI-TOF Biotyper® (Bruker Daltonik, Massachusetts, USA). The bacterial isolates were revived from glycerol-preserved stocks by seeding them on a 5% - 10% sheep blood agar plate and incubated at 37°C for 24 hours or until visible growth was observed on the plate. The bacterial isolates were spotted from a single colony onto a MALDI-TOF MS 48-well target plate per the manufacturer's instructions and identified by the machine. The results were confirmed with tuf gene sequence typing described by Hwang et al. [8]. Briefly, polymerase chain reaction (PCR) amplification of the tuf gene was performed on a C1000 Touch™ Thermal Cycler (BioRad) by applying a set of primers 5´-GCCAGTTGAGGACGTATTCT-3' and 5´-CCATTTCAGTACCTTCTGGTAA-3', which amplify a 412 bp fragment of the tuf gene. The PCR products were aliquoted (46μl) into 1 ml Eppendorf tubes, sealed, and shipped to GENEWIZ-Brooks Life Sciences, Leipzig, Germany, for tuf gene sequencing. Deoxyribonucleic acid (DNA) sequencing was done by the Sanger method. The obtained sequences of the tuf gene for each isolate were aligned separately by Molecular Evolutionary Genetics Analysis (MEGA 5) software and compared with all existing sequences of CoNS annotated in the GenBank database.

Antimicrobial susceptibility testing: overnight cultured bacterial isolates on blood agar media were observed for purity, and 0.5 McFarland concentrations were made with the manufacturer's diluent and checked with a benchtop turbidimeter. The inoculum was added to a VITEK 2 AST card according to the manufacturer's instructions. The reagent card was inserted into the machine for analysis. A purity check plate was performed by plating the diluted suspension on blood agar and incubating aerobically at 37°C overnight. The MICs of 17 antibiotics were determined for these strains by VITEK 2®machine (bioMérieux, Durham, USA). S. aureus NCTC 12493 was included as a susceptible quality control strain. The MIC results were interpreted according to the 2018 European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoints. The MICs of mupirocin, teicoplanin, vancomycin, and tobramycin were also tested using gradient strips (E-test®; Liofilchem® s.r.l., Italy) using Mueller-Hinton E agar (bioMérieux SA, Strasbourg, France).

Statistical analysis: data were entered into an excel spreadsheet and imported into the Grad-Pad Prism version. The frequencies and percentages were derived as part of descriptive statistics.

Institutional review board statement: the Research Ethics Committee of the University of Health and Allied Sciences (UHAS), Ghana, reviewed and approved this study with Protocol Identification Number UHAS-REC/A.2 [4] 17-18. Written approval was also obtained from the Ho Teaching Hospital (HTH) to use the facility for the study.

Informed consent statement: informed consent was obtained from all subjects involved in the study.



Results Up    Down

Minimum inhibitory concentrations: minimum inhibitory concentrations were obtained on an automated analyzer and then confirmed with Epsilometer. This study has identified resistance to one 'Watch' antimicrobial group (teicoplanin), two 'Reverse' groups (tigecycline and fosfomycin), and mupirocin, an unclassified group.

For S. epidermidis species, the highest methicillin resistance was identified among the isolates of the residence groups, clinical staff (65%), and young infants (50%), who represented the residents to the Ho Teaching Hospital. Rare resistance to the fluroquinolones antibiotic class was observed among the non-residence group (Table 1). Apart from fosfomycin, there was no resistance to the reserve group of antimicrobials tested. High resistance to tetracycline was identified for isolated colonizing mothers, who represent the transient residents of the HTH.

In the case of S. haemolyticus species, methicillin resistance was relatively high for all four groups with young neonates and clinical staff's isolates having 100% methicillin-resistant each. Teicoplanin resistance was seen among the isolates of young infants and mother groups but not in residence (clinical staff) and non-residence (students) groups. Isolates of the residence group have the highest resistance to the fluroquinolone class of antibiotics (Table 2). This staphylococcal species showed resistance to two reserve antimicrobial groups: fosfomycin and tigecycline. Both young infants and mothers' groups demonstrated the highest resistance to the antibiotic tetracycline.



Discussion Up    Down

In our study, coagulase-negative staphylococci (CoNS) isolated from blood samples of young infants, nasal mucosae of mothers, clinical staff, and students were analyzed, and selected CoNS isolates were compared in terms of susceptibility and resistance. VITEK2 was employed for antimicrobial susceptibility testing, and the resistance to some of the watch and reserve groups was confirmed with Epsilometer Test. CoNS were once thought incapable of inducing major clinical infections and were discarded as contamination when identified in cultures [9]. However, CoNS has been implicated in the development of neonatal sepsis in several studies, as babies treated in the NICU are regularly subjected to invasive and semi-invasive procedures that have a high risk of introducing bacteria into the bloodstream [10]. A high prevalence of healthcare workers and students have also been identified as nasal carriers of CoNS exhibiting different antimicrobial resistance profiles, including methicillin and multidrug-resistant [11,12]. CoNS have become one of the most common nosocomial infections resulting from patient's and procedure-related alterations, with S. epidermidis and S. haemolyticus being the most common species [6]. Our study revealed that S. epidermidis isolates from clinical staff have the highest methicillin resistance (65%), followed by young infants' (50%) and mothers and students' (25% each). These findings show that methicillin-resistant S. epidermidis is more prevalent in the HTH than in the normal community. A similar conclusion was obtained for S. aureus, with Bryna Warshawsky et al. identifying hospital contact as the single most important risk factor for MRSA acquisition [13]. S. haemolyticus isolates from newborn infants and clinical staff are 100% methicillin-resistant, while those from mothers and students are 82% and 63% methicillin-resistant, respectively. Similarly, a study carried out in a neonatal unit of a hospital in New Delhi reported a higher frequency of methicillin-resistant S. haemolyticus isolates than S. epidermidis isolated at the same time [14]. According to the authors, S. haemolyticus with three resistance patterns, including methicillin, were isolated from nasal cavities of mothers and staff in an adjacent maternity ward [14].

Microbes rapidly colonize neonates from the environment within the first week of life [15]. The use of central venous catheters (CVC), mechanical ventilation, parenteral feeding, and other invasive skin- or mucosa-breaching treatments significantly increases the risk of CoNS infection during this time [15,16]. CoNS are common occupants of the skin and mucous membranes; although a small percentage of neonates acquire CoNS through vertical transmission, the acquisition is usually horizontal. As a result, infants in the neonatal unit of hospitals get most of their microorganisms from the hospital environment, their parents, and the staff [15]. Antibiotic resistance in the skin and nasal-residing strains have been found to be low at birth but increase rapidly during the first week of hospitalization [17]. Previous studies have shown that transmission through the hands of staff and students at the hospital can result in endemic strains circulating for an extended period of time [18,19].

The rise of multidrug-resistant CoNS has made treating its associated diseases incredibly challenging. Studies have shown aside methicillin; CoNS are resistant to multiple antimicrobials, including tigecycline [20], teicoplanin [21], linezolid [20], and daptomycin [20]. In this study, we identified resistance of CoNS isolates to one watch (teicoplanin), two reserves (tigecycline and fosfomycin) antimicrobial groups, and mupirocin, an unclassified group. S. epidermidis isolates resistant to teicoplanin were seen among only students, while high resistance to tetracycline was identified for isolates colonizing mothers. Moreover, Adeapena et al. [22] reported tetracycline as the most widely administered antibiotic for animals in Ghana. In addition, over-the-counter antibiotics [23] and self-medication [24] are widespread among community members in Ghana. According to a Ghanaian study, community members insisted on purchasing specific antibiotics due to previous use and awareness of their effectiveness [23]. This could explain our present observation that tetracycline and teicoplanin resistance are more widespread in the Ho community than in hospitals. Regarding S. haemolyticus, teicoplanin resistance was seen among the isolates of young infants and mothers, while isolates from hospital staff had the highest resistance to the fluoroquinolone class of antibiotics. We have previously reported the antibiotics prescribed for young infants in the NICU of the HTH to include: ampicillin, amikacin, benzylpenicillin, cefotaxime, flucloxacillin, gentamicin and metronidazole [7]. Fluoroquinolones are not prescribed in the NICU hence we find it difficult to explain the high resistance of this class of antibiotics among the clinical staff of the HTH and calls for further research.

A study carried out by Mehri et al. showed a higher rate of multidrug-resistant isolates of S. haemolyticus and S. epidermidis, including resistance to teicoplanin. The authors concluded that teicoplanin might not be an effective first-line antibiotic for treating infections caused by these CoNS [21]. The current study discovered S. haemolyticus isolates that are resistant to tigecycline, a reserve group antibiotic defined by the WHO. Tigecycline belongs to the class of antibiotics known as glycylcyclines, which block protein synthesis and have action against a wide range of gram-positive and gram-negative organisms, including MRSA, vancomycin-resistant Enterococcus spp., and other difficult-to-treat pathogens [25]. As a derivative of minocycline, tigecycline prevents bacterial protein synthesis by attaching to the 30S subunit of the ribosome. However, it is not affected by classical mechanisms of resistance to tetracyclines, such as specific efflux pumps and ribosome protection [26,27]. Fosfomycin was another reserve group antimicrobial drug that showed resistance in S. epidermidis and S. haemolyticus isolates. Fosfomycin inhibits the formation of peptidoglycan precursors, causing bacterial cells to die. However, we will not go into detail about this antibiotic because we have not established its MICs with the Epsilometer Test, which is a limitation of our study.



Conclusion Up    Down

Taking together, this current study has drawn attention to the significant prevalence of methicillin-resistant CoNS in the NICU of the Ho Teaching Hospital, which may have been spread through nasal mucosae of mothers and clinical personnel. As a result, critical steps are required to eradicate these strains of CoNS in the NICU since these strains have been implicated in the development of neonatal sepsis. Also, the identification of CoNS resistance to watch and reserve groups of antimicrobials in a non-previously exposed hospital calls for further studies to determine molecular mechanisms of resistance to these antimicrobials.

What is known about this topic

  • CoNS, mostly S. epidermidis, and S. haemolyticus are the most frequent pathogens causing neonatal sepsis, especially late-onset sepsis in most neonatal intensive care units;
  • Studies mostly conducted in developed countries have identified resistance of CoNS to some World Health Organization's classified reserve group of antimicrobials like tigecycline, daptomycin and linezolid;
  • Resistance of CoNS isolates from developing countries, where reverse antimicrobials are hardly used, is a gap in research.

What this study adds

  • Resistance to tigecycline of S. haemolyticus isolates but not S. epidermidis was observed and called for further molecular studies to understand the mechanisms of resistance of S. haemolyticus isolate cultured in a non-previously exposed tigecycline hospital to tigecycline;
  • This study observed high resistance to fosfomycin, a reverse-classified antibiotic, for S. epidermidis and S. haemolyticus isolates and calls for further research since fosfomycin is not a common antibiotic used in the study region;
  • Higher methicillin resistance in S. haemolyticus is observed among individuals that had contact with a hospital facility than those who did not.



Competing interests Up    Down

The authors declare no competing interests.



Authors' contributions Up    Down

Conceptualization: Innocent Afeke, Kokou Hefoume Amegan-Aho, Anthony Ablordey, and Graceful Lord Mensah; methodology: Innocent Afeke, Verner Ndudiri Orish, and Ibrahim Jamfaru; software: Abdul-Wahab Mawuko Hamid; validation: Kokou Hefoume Amegan-Aho, Lennox Mac Ankrah, John Korbuvi, and Kokou Hefoume Amegan-Aho; formal analysis: Innocent Afeke, Hintermann Kobina Mbroh, Ibrahim Jamfaru, Lennox Mac Ankrah and Joseph Adu-Amankwaah; investigation: Innocent Afeke, Kokou Hefoume Amegan-Aho, Joseph Adu-Amankwaah, Graceful Lord Mensah, and Hintermann Kobina Mbroh; resources: Anthony Ablordey and John Korbuvi; data curation: Innocent Afeke, Graceful Lord Mensah and Abdul-Wahab Mawuko Hamid; writing-original draft preparation: Innocent Afeke; writing-review and editing: Joseph Adu-Amankwaah, Ibrahim Jamfaru, Verner Ndudiri Orish, Hintermann Kobina Mbroh, John Korbuvi, and Lennox Mac Ankrah; visualization: Abdul-Wahab Mawuko Hamid; supervision: Anthony Ablordey, and Verner Ndudiri Orish; project administration: Innocent Afeke; funding acquisition: Innocent Afeke. All the authors read and approved the final version of this manuscript.



Acknowledgments Up    Down

We are grateful to all the clinical staff at the HTH, the babies' mothers, and the medical and nursing students of UHAS who participated in our study. We are also grateful to Prof. Dr. Saleh Ibrahim of the Institute for Experimental Dermatology, University of Luebeck, and his staff for their help. We thank Prof. Dr. Jan Rupp, Prof. Dr. Christoph Härtel, and staff of the Department of Infectious Diseases and Microbiology, University of Luebeck, and the HTH laboratory for their support. Prof. Ahmed Moustafa of the American University of Cairo, Egypt, is thanked for his technical support. We are grateful to Deutscher Akademischer Austauschdienst (DAAD) for offering a scholarship to the Ph.D. candidate (IA).



Tables Up    Down

Table 1: percentage antimicrobial resistance for Staphylococcus epidermidis isolates

Table 2: percentage antimicrobial resistance for Staphylococcus haemolyticus isolates



References Up    Down

  1. Baptista PV, McCusker MP, Carvalho A, Ferreira DA, Mohan NM, Martins M et al. Nano-Strategies to Fight Multidrug Resistant Bacteria-"A Battle of the Titans". Front Microbiol. 2018 Jul 2;9:1441. PubMed | Google Scholar

  2. Johnson CL, Saiman L. A Blueprint for Targeted Antimicrobial Stewardship in Neonatal Intensive Care Units. Infect Control Hosp Epidemiol. 2017 Oct;38(10):1144-6. PubMed | Google Scholar

  3. World Health Organization. Critically Important Antimicrobials for Human Medicine. Geneva: World Health Organization. 2017;5.

  4. World Health Organization. The selection and use of essential medicines. World Health Organ Tech Rep Ser. 2011;(965):i-xiv, 1-249. PubMed | Google Scholar

  5. World Health Organization. Global action plan on antimicrobial resistance. Microbe Magazine. 2015;10(9):354-5.

  6. Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014 Oct;27(4):870-926. PubMed | Google Scholar

  7. Afeke I, Hirose M, Amegan-Aho KH, Haertel C, Becker M, Moustafa A et al. Neonatal and Young Infant Sepsis in a Regional Hospital in Ghana. Open Journal of Pediatrics. 2021;11(2):281-300. Google Scholar

  8. Hwang SM, Kim MS, Park KU, Song J, Kim EC. Tuf gene sequence analysis has greater discriminatory power than 16S rRNA sequence analysis in identification of clinical isolates of coagulase-negative staphylococci. J Clin Microbiol. 2011 Dec;49(12):4142-9. PubMed | Google Scholar

  9. Lutro O, Langvatn H, Dale H, Schrama JC, Hallan G, Espehaug B et al. Increasing Resistance of Coagulase-Negative Staphylococci in Total Hip Arthroplasty Infections: 278 THA-Revisions due to Infection Reported to the Norwegian Arthroplasty Register from 1993 to 2007. Adv Orthop. 2014;2014:580359. PubMed | Google Scholar

  10. Shivanna V, Sunkappa SR, Venkatesha D. The rising trend of coagulase-negative staphylococci in neonatal septicemia. Indian J Pathol Microbiol. 2016 Oct-Dec;59(4):510-2. PubMed | Google Scholar

  11. Baragundi MC, Solabannavar SS, Gokale SK, Sonth SB. Methicillin and multidrug resistant coagulase negative staphylococcal nasal carriage in medical students. J Commun Dis. 2012 Dec;44(4):231-7. PubMed | Google Scholar

  12. Eladli MG, Alharbi NS, Khaled JM, Kadaikunnan S, Alobaidi AS, Alyahya SA. Antibiotic-resistant Staphylococcus epidermidis isolated from patients and healthy students comparing with antibiotic-resistant bacteria isolated from pasteurized milk. Saudi J Biol Sci. 2019 Sep;26(6):1285-90. PubMed | Google Scholar

  13. Warshawsky B, Hussain Z, Gregson DB, Alder R, Austin M, Bruckschwaiger D et al. Hospital- and community-based surveillance of methicillin-resistant Staphylococcus aureus: previous hospitalization is the major risk factor. Infect Control Hosp Epidemiol. 2000 Nov;21(11):724-7. PubMed | Google Scholar

  14. Mehta G, Kumari S. Multi-resistant Staphylococcus haemolyticus in a neonatal unit in New Delhi. Ann Trop Paediatr. 1997 Mar;17(1):15-20. PubMed | Google Scholar

  15. Marchant EA, Boyce GK, Sadarangani M, Lavoie PM. Neonatal sepsis due to coagulase-negative staphylococci. Clin Dev Immunol. 2013;2013:586076. PubMed | Google Scholar

  16. Healy CM, Baker CJ, Palazzi DL, Campbell JR, Edwards MS. Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit. J Perinatol. 2013 Jan;33(1):52-8. PubMed | Google Scholar

  17. Hira V, Kornelisse RF, Sluijter M, Kamerbeek A, Goessens WH, de Groot R et al. Colonization dynamics of antibiotic-resistant coagulase-negative Staphylococci in neonates. J Clin Microbiol. 2013 Feb;51(2):595-7. PubMed | Google Scholar

  18. Milisavljevic V, Wu F, Cimmotti J, Haas J, Della-Latta P, Larson E et al. Genetic relatedness of Staphylococcus epidermidis from infected infants and staff in the neonatal intensive care unit. Am J Infect Control. 2005 Aug;33(6):341-7. PubMed | Google Scholar

  19. Björkqvist M, Liljedahl M, Zimmermann J, Schollin J, Söderquist B. Colonization pattern of coagulase-negative staphylococci in preterm neonates and the relation to bacteremia. Eur J Clin Microbiol Infect Dis. 2010 Sep;29(9):1085-93. PubMed | Google Scholar

  20. Shariati A, Dadashi M, Chegini Z, van Belkum A, Mirzaii M, Khoramrooz SS et al. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2020;9(1):56. PubMed | Google Scholar

  21. Mehri H, Jahanbakhsh R, Shakeri F, Ardebili A, Behnampour N. Investigation of Glycopeptide Susceptibility of Coagulase-Negative Staphylococci (CoNS) From a Tertiary Care Hospital in Gorgan, Northern Iran. Arch Pediatr Infect Dis. 2017;5(1):e37264. Google Scholar

  22. Adeapena W, Afari-Asiedu S, Najjemba R, Griensven JV, Delamou A, Ohene Buabeng K et al. Antibiotic Use in a Municipal Veterinary Clinic in Ghana. Trop Med Infect Dis. 2021 Jul 20;6(3):138. PubMed | Google Scholar

  23. Afari-Asiedu S, Kinsman J, Boamah-Kaali E, Abdulai MA, Gyapong M, Sankoh O et al. To sell or not to sell; the differences between regulatory and community demands regarding access to antibiotics in rural Ghana. J Pharm Policy Pract. 2018 Dec 14;11:30. PubMed | Google Scholar

  24. Mensah BN, Agyemang IB, Afriyie DK, Amponsah SK. Self-medication practice in Akuse, a rural setting in Ghana. Niger Postgrad Med J. 2019 Jul-Sep;26(3):189-94. PubMed | Google Scholar

  25. Stein GE, Babinchak T. Tigecycline: an update. Diagn Microbiol Infect Dis. 2013 Apr;75(4):331-6. PubMed | Google Scholar

  26. Goktas S, Kurtoglu MG, Sakarya Y, Ugurluoglu C, Ozcimen M, Sakarya R et al. New therapy option for treatment of methicillin-resistant Staphylococcus aureus keratitis: tigecycline. J Ocul Pharmacol Ther. 2015 Mar;31(2):122-7. PubMed | Google Scholar

  27. McAleese F, Petersen P, Ruzin A, Dunman PM, Murphy E, Projan SJ et al. A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline. Antimicrob Agents Chemother. 2005 May;49(5):1865-71. PubMed | Google Scholar